MHESI Minister Visits Genepeutic Bio’s Cell and Gene Production Unit

  • News & Events

On 29 May 2024, the Minister of Higher Education, Science, Research and Innovation (MHESI), Ms. Supamas Isarabhakdi, visited the Cell and Gene Production Unit (CPU) operated by the Thailand Center of Excellence for Life Sciences (TCELS) together with executives and researchers from Genepeutic Bio.

The visit highlighted Thailand’s progress in developing domestic CAR T-cell manufacturing capability to accelerate cancer treatment and improve patient survival, joined by leadership from TCELS, NSTDA and national research funding agencies.

This is an English summary. อ่านฉบับภาษาไทย: คลิกที่นี่

  • Share this article
  • News & Events

Mahidol University Announces Successful CAR T-Cell Treatment of 10 Patients

On 19 April 2023, Mahidol University announced the success of Thailand’s first CAR T-cell therapy program manufactured under international standards — the first of its kind in ASEAN. Ten patients, both children and adults, with blood cancers resistant to multiple chemotherapy regimens and targeted therapies were treated with CD19
Read More
  • News & Events

THEIR OWN MEDICINE : Our Story from The Economist

Biotech entrepreneurs are building on Thailand’s robust industry ecosystem to make advanced health care more accessible.
Read More
  • News & Events

Genepeutic Bio Gets Supports from Thailand Board of Investment

Thai Board of Investments approves business promotions for 4 new Biotech Project including Genepeutic Bio project for developing advanced cell therapy medicines.
Read More

GENEPEUTIC BIO CO.,LTD

Genepeutic Bio was founded in 2020 to deliver the next wave of personalized cell and gene therapy for patients in Asia, initiating with Chimeric antigen receptor (CAR) T-cells.

NAVIGATION

HOME

SERVICES AND SOLUTIONS

OUR SCIENCES

PRODUCT

ABOUT

NEWS & EVENTS

CONTACT

GNPT - FACT SHEET ( PDF )

CONTACT US